Description
Description
Tirzepatide (5mg) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is used in laboratory research to study its biological impact on metabolic pathways and insulin secretion.
Research Applications
Investigations focus on the synergistic effects of dual incretin receptor activation in experimental models.
Reviews
There are no reviews yet.